We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A strategy to discover decoy chemokine ligands with an anti-inflammatory activity.
- Authors
Abboud, Dayana; Daubeuf, François; Quoc Tuan Do; Utard, Valérie; Villa, Pascal; Haiech, Jacques; Bonnet, Dominique; Hibert, Marcel; Bernard, Philippe; Galzi, Jean-Luc; Frossard, Nelly
- Abstract
Excessive signaling by chemokines has been associated with chronic inflammation or cancer, thus attracting substantial attention as promising therapeutic targets. Inspired by chemokine-clearing molecules shaped by pathogens to escape the immune system, we designed a generic screening assay to discover chemokine neutralizing molecules (neutraligands) and unambiguously distinguish them from molecules that block the receptor (receptor antagonists). This assay, called TRIC-r, combines time-resolved intracellular calcium recordings with pre-incubation of bioactive compounds either with the chemokine or the receptor-expressing cells. We describe here the identification of high affinity neutraligands of CCL17 and CCL22, two chemokines involved in the Th2-type of lung inflammation. The decoy molecules inhibit in vitro CCL17- or CCL22-induced intracellular calcium responses, CCR4 endocytosis and human T cell migration. In vivo, they inhibit inflammation in a murine model of asthma, in particular the recruitment of eosinophils, dendritic cells and CD4+T cells. Altogether, we developed a successful strategy to discover as new class of pharmacological tools to potently control cell chemotaxis in vitro and in vivo.
- Subjects
CHEMOKINES; LIGANDS (Biochemistry); CANCER treatment; BIOACTIVE compounds; PNEUMONIA treatment; ENDOCYTOSIS; T cells; CELL migration; GENETICS
- Publication
Scientific Reports, 2015, p1
- ISSN
2045-2322
- Publication type
Article
- DOI
10.1038/srep14746